Henry Schein, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 80 Summit View Ln, Bastian, Virginia (VA) 24134, United States (USA)
- Operations here
- relabelrepack
- FDA identifiers
- FEI 1121774 · DUNS 830995189
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-07-13
- NAIDrug Quality Assurance2017-06-29
Drugs this plant is listed as making
17 distinct drugs across 20 products name this site in their FDA label.
- Atropine Sulfatein shortageHenry Schein, Inc.
- bupivacine hydrochlorideHenry Schein, Inc.
- Calcium GluconateHenry Schein, Inc.
- cefazolinHenry Schein, Inc.
- Clindamycin Phosphatein shortageHenry Schein, Inc.
- diazepamHenry Schein, Inc.
- esmolol hydrochlorideHenry Schein, Inc.
- ketamine hydrochlorideHenry Schein, Inc.
- Ketorolac tromethaminein shortageHenry Schein, Inc.
- lidocaine hydrochloridein shortageHenry Schein, Inc.
- LIDOCAINE HYDROCHLORIDE and EPINEPHRINEin shortageHenry Schein, Inc.
- Magnesium SulfateHenry Schein, Inc.
- metronidazolein shortageHenry Schein, Inc.
- Midazolamin shortageHenry Schein, Inc.
- sodium bicarbonatein shortageHenry Schein, Inc.
- Sodium ChlorideHenry Schein, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.